Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreThe Centers for Disease Control and Prevention (CDC) alerted healthcare facilities about non-sterile ultrasound gel products — MediChoice® [lots: 240302 and 240306] and ClearImage® [lots: 230221, 230256, 240227, and 240230] — contaminated with an environmental bacterium, Paraburkholderia fungorum. The CDC confirmed 40 cases of P. fungorum in patients who were exposed to contaminated non-sterile ultrasound gel products in four states.
The agency urges healthcare providers to ensure patient safety by only using single-use ultrasound gels that are labeled “sterile” before and during percutaneous procedures. The full alert and more information is on the CDC website.
Favorable Decision for ACR Members in “TMA III” NSA Case
Fifth Circuit ruling on No Surprises Act QPA calculations supports fair physician reimbursement and stronger insurer accountability.
Read moreRAPID Pathway for Device Coverage
RAPID pathway could streamline Medicare coverage decisions for eligible breakthrough devices through earlier review alignment.
Read moreDetailed Summary of FY2027 IPPS Final Rule
CMS finalized FY 2027 hospital payment updates, including a 2.3% increase, new technology payments and AI-related policy changes.
Read more